The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Healthcare Contract Win

27 Dec 2018 07:00

RNS Number : 4904L
WANdisco Plc
27 December 2018
 

27 December 2018

WANdisco plc

 

("WANdisco," the "Company" or the "Group")

 

Healthcare Contract Win

 

$700k contract for disaster recovery via IBM

 

WANdisco (LSE: WAND), the LiveData company, is pleased to announce, that through its OEM sales partnership with IBM, the Company has secured a contract with a major American managed healthcare company (the "Client"). The agreement will see IBM deploy the Company's patented Big Data and Cloud product, WANdisco Fusion.

 

The three-year agreement is valued at approximately $700k in royalties to be paid to WANdisco. Earlier this year, WANdisco significantly expanded its relationship with IBM, increasing the royalty percentage to 50% (previously 30%) and agreeing a guaranteed annual royalty commitment. In addition, WANdisco has also engaged in joint engineering work to support IBM BigSQL and other products, expanding the total addressable market.

 

The Client has substantial data requirements with over 45 million customers and 5,700 hospitals in its network and is using Fusion on-premise for replication and disaster recovery. It is also the first sale of WANdisco's newly released Live backup solution. WANdisco Fusion for Disaster Recovery is the only solution which ensures no downtime and no data loss in a disaster recovery scenario. WANdisco Fusion guarantees global data consistency and accessibility for a company's critical applications, protecting data in the event of a disaster without impacting on-premise or cloud application performance.

 

David Richards, Chief Executive Officer and Chairman of WANdisco, commented:

 

"We are continuing to gain strong traction in industries where critical data is needed to be continuously available. This is the second major healthcare deal we have agreed this month and follows our largest ever cloud deal valued at $3 million. Our pipeline with IBM continues to build and our expanded relationship means we can efficiently and profitably service on-premise contracts."

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by David Richards, CEO and Chairman.

 

For further information please contact:

 

WANdisco plc

David Richards, Chief Executive Officer and Chairman

Erik Miller, Chief Financial Officer

via FTI Consulting

FTI Consulting

Matt Dixon / Harry Staight / Chris Birt / Kwaku Aning

+44 (0)20 3727 1137

Stifel (Nomad and Joint Broker)

Fred Walsh / Neil Shah / Alex Price / Rajpal Padam

+44 (0)20 7710 7600

Peel Hunt (Joint Broker)

Edward Knight / Nick Prowting

+44 (0)20 7418 8900

WH Ireland Limited (Joint Broker)

Adam Pollock

+44 (0)20 7220 1666

 

 

About WANdisco

WANdisco is shaping the future of data infrastructure with its groundbreaking Live Data platform, enabling companies to put all their data to work for the business - all the time, at any scale.

WANdisco makes data always available, always accurate, and always protected, delivering hyperscale economics to support exponential data growth with the same IT budget. With significant OEM relationships with IBM and Dell EMC and go-to-market partnerships with Amazon Web Services, Cisco, Microsoft Azure, Google Cloud, Hewlett Packard Enterprise, Oracle and other industry titans - as well as hundreds of customers among the Global 2000 - WANdisco is igniting a Live Data movement worldwide.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTLQLLLVLFLFBB
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.